References
- Graft DF. Venom immunotherapy: indications, selection of venom techniques, and efficacy. In: Levine MI, Lockey RF, eds. Monograph on insect allergy. 4th ed. Pittsburgh: Dave Lambert, 2003: 103–12
- Golden DB. Insect allergy. In: Adkinson NF Jr, Yunginger JW, Busse WW, et al, eds. Middleton's allergy principles and practice. 6th ed. Philadelphia: Mosby, 2003: 1475–86
- Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299(4): 157–61
- Smith PL, Kagey-Sobotka A, Bleecker ER, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66(5): 1072–80
- Graft DF. Allergic reactions to insect stings. In: Rakel RE, Bope ET, eds. Conn's current therapy 2004. Philadelphia: Saunders, 2004: 819–21
- Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990; 323(23): 1601–3
- Golden DB, Kagey-Sobotka A, Norman PS, et al. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 2004; 351(7): 668–74
- Golden DB, Kagey-Sobotka A, Norman PS, et al. Insect sting allergy with negative venom skin test responses. J Allergy Clin Immunol 2001; 107(5): 897–901
- Oude Elberink JN, de Monchy JG, van der Heide S, et al. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002; 110(1): 174–82
- van der Linden PW, Hack CE, Struyvenberg A, et al. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis. J Allergy Clin Immunol 1994; 94(2 Pt 1): 151–9
- Franken HH, Dubois AE, Minkema HJ, et al. Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol 1994; 93(2): 431–6
- Graft DF, Golden DB, Reisman RE, et al. The discontinuation of Hymenoptera venom immunotherapy. American Academy of Allergy, Asthma, and Immunology position statement. J Allergy Clin Immunol 1998; 101(5): 573–5